Midday movers: Bristol-Myers, 3M and Deckers rise; Dexcom falls

Investing.com -- U.S. stock futures rose Friday, rebounding after hefty losses in megacap tech this week, as inflation data was in-line with consensus.

Here are some of the biggest U.S. stock movers today:

3M Company (NYSE: MMM) stock rose 17% after the industrial conglomerate raised the low end of its full-year adjusted profit forecast expecting to benefit from restructuring measures and increasing demand for electronics.

Bristol-Myers Squibb (NYSE: BMY) stock rose 8% after the drugmaker posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top-seller, blood thinner Eliquis.

Apple (NASDAQ: AAPL) stock rose 0.2%, boosted by the positive overall tone despite its smartphone shipments in China falling by 6.7% in the second quarter of 2024, according to data from market research firm Canalys.

Novo Nordisk (NYSE: NVO) stock fell 0.4% despite the drugmaker’s blockbuster Wegovy weight loss drug receiving backing from the European Union’s medical regulator backing to reduce heart risks.

Deckers Outdoor (NYSE: DECK) stock soared 8% after the athletics shoes and apparel company raised its annual profit forecast following a first-quarter results beat.

Dexcom (NASDAQ: DXCM) stock slumped 41% after the medical device maker cut its annual revenue forecast, saying it had fewer new customers than expected.

Baker Hughes (NASDAQ: BKR) stock rose 4.5% after the oilfield services firm beat estimates for second-quarter profit, helped by a strong international performance.

Charter Communications (NASDAQ: CHTR) stock soared 15% after the cable company beat second-quarter earnings expectations.

Walmart (NYSE: WMT) stock fell 0.6% after Reuters reported that the retail giant plans to potentially spend $200 million on self-driving forklifts as part of broader efforts to automate more warehouse operations.

Saia, Inc. (NASDAQ: SAIA) fell 20% after reporting disappointing second quarter results despite high expectations heading into the print.

Aon plc (NYSE: AON) rose 7%, the most in three years, after second quarter revenue beat the average analyst estimate. Results reflect organic revenue growth of 6% in its Commercial Risk Solutions.

Biogen (NASDAQ: BIIB) fell 6% after the European Medicines Agency adopted a negative opinion on the Marketing Authorization Approval for its treatment for early Alzheimer’s disease.

Norfolk Southern (NYSE: NSC) rose 10% after delivered solid second quarter results, with improvement in its operating ratio and expenses.

Additional reporting by Louis Juricic

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Rocket Lab launches U.S. Space Force mission in record 16 hours